Form 8-K - Current report:
SEC Accession No. 0001213900-26-042468
Filing Date
2026-04-10
Accepted
2026-04-10 16:05:30
Documents
12
Period of Report
2026-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0285909-8k_ispecimen.htm   iXBRL 8-K 23394
2 PRESS RELEASE DATED APRIL 9, 2026 ea028590901ex99-1.htm EX-99.1 8022
  Complete submission text file 0001213900-26-042468.txt   200870

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ispc-20260409.xsd EX-101.SCH 3017
4 XBRL LABEL FILE ispc-20260409_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ispc-20260409_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0285909-8k_ispecimen_htm.xml XML 3310
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 26854850
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)